Latest Islet cell transplantation Stories
Cutting-edge DNA testing technology provided by GeneSeek Inc. LINCOLN, Neb., Feb.
Early attempts at islet cell transplantation to treat diabetes date to the nineteenth century, decades before the discovery of insulin in the 1930s.
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
MINNEAPOLIS and ST. PAUL, Minn., Dec. 11 /PRNewswire/ -- The University of Minnesota has received a $40 million pledge for diabetes research from the Richard M. Schulze Family Foundation.
Kidney disease patients' ability to understand basic health information may have a significant impact on whether or not they will receive an organ transplant
Researchers identified a new source of insulin-producing cells.
Doctors have tricked mouse immune systems into thinking cells from a donor pancreas are theirs, bringing hope to diabetes patients, U.S.
HOLLYWOOD, Fla., Nov.
SAN FRANCISCO, Oct. 29 /PRNewswire/ -- Two studies presented at the annual meeting of the American Association for the Study of Liver Diseases paint a different picture of survival based on racial group for adult and child recipients of liver transplants.
DiaKine Therapeutics, a development-stage company commercializing immune modulators for the treatment of diabetes and related complications, has announced that a Phase II clinical trial with the company's lead drug candidate, Lisofylline, is underway.